Patents by Inventor Frank-Thorsten Hafner

Frank-Thorsten Hafner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-Arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
    Publication number: 20070105881
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Application
    Filed: June 16, 2004
    Publication date: May 10, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Martin Hendrix, Lars Barfacker, Bettina Beyreuther, Ulrich Ebert, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Yan-Hong Liu, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolepyrimidines
    Publication number: 20070105876
    Abstract: The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: April 28, 2004
    Publication date: May 10, 2007
    Inventors: Martin Hendrix, Lars Barfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Aza-bicyclic N-biarylamides with affinity for the ?7 nicotinic acetylcholine receptor
    Patent number: 7138410
    Abstract: The invention relates to novel 1-aza-bicyclic N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: November 21, 2006
    Assignee: Bayer HealthCare AG
    Inventors: Joachim Luithle, Frank-Gerhard Böss, Christina Erb, Katrin Schnizler, Timo Flessner, Marja van Kampen, Christoph Methfessel, Frank-Thorsten Hafner
  • 7H-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof
    Publication number: 20060247303
    Abstract: The present invention relates to substituted 7H-dibenzo[b,g][1,5]dioxocin-5-one-derivatives, to processes for their preparation and to their use in medicaments, in particular as inhibitors of the cholesterol ester transfer protein (CETP) for the treatment and/or prevention of cardiovascular disorders, in particular hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias and arteriosclerosis.
    Type: Application
    Filed: October 21, 2003
    Publication date: November 2, 2006
    Applicant: BAYER HEALTHCARE AG
    Inventors: Hilmar Bischoff, Frank-Thorsten Hafner, Carsten Schmeck, Joachim Telser, Alexandros Vakalopoulos, Gabriele Wirtz, Marcus Bauser, David Bruckner, Martina Wuttke
  • 2-Heteroaryl carboxamides
    Publication number: 20060160877
    Abstract: The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: June 2, 2003
    Publication date: July 20, 2006
    Inventors: Joachim Luithle, Frank-Gerhard Boss, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Timo Flessner, Marja Kampen, Franz-Josef Staay
  • Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
    Publication number: 20060106096
    Abstract: The invention relates to novel benzothiophene-, benzofuran- and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: July 14, 2003
    Publication date: May 18, 2006
    Applicant: BAYER HEALTH AG
    Inventors: Timo Flessner, Frank-Gerhard Bossw, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Dieter Lang, Joachim Luithle, Marja Van Kampen, Franz-Josef Van der Staay
  • Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
    Publication number: 20050154045
    Abstract: The invention relates to novel 1-aza-bicyclic N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning ability and memory.
    Type: Application
    Filed: March 3, 2003
    Publication date: July 14, 2005
    Applicant: Bayer Healthcare AG
    Inventors: Joachim Luithle, Frank-Gerhard Boss, Christiana Erb, Katrin Schnizler, Timo Flessner, Marja Kampen, Christoph Methfessel, Frank-Thorsten Hafner